- Anti-inflammatory enzyme produced by the Serratia bacteria.
- Helps reduce pain and inhibit damaged tissue factors.
- Generating interest for the treatment of pharyngitis and sinusitis.
Serratia peptidase, or serrapeptase, is a proteolytic enzyme produced by the Serratia bacteria that lives in the intestines of silkworms. Serrapeptase has been used successfully for almost 40 years in Europe and Asia to treat pain, inflammation, trauma-induced swelling and excessive mucous secretion.
Because serrapeptase is able to digest dead tissue - indeed, this is how it releases the silkworm from its cocoon - it can be used to restrict arterial obstruction (atheromatous plaques) and facilitate circulation. Hans Neiper, the world-renowned German doctor and scientist, has reported significant improvements from serrapeptase treatment in the circulation of a number of patients with previously compressed arteries. Serrapeptase can also:
As with all enzymes, serrapeptase is sensitive to stomach acids. To improve its efficacy and bioavailability, new technology has enabled it to be produced in a gastroresistant form, DR Caps, which release their content only in the small intestine.
|Daily dosis : 2 DR Caps™ capsules
Number of doses per pack: 45
|Amount per dose|
|Serrapeptase (gastroresistant fine granules of Serratia peptidase 2000 units/mg)||120 000 IU|
| Other ingredients: Acacia gum, rice bran.